Global Pigmentation Disorders Treatment Market Analysis, Trends, Market Size, and Forecasts up to 2024 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pigmentation
Disorders Treatment Market: Global Industry Analysis, Trends, Market
Size, and Forecasts up to 2024”
report has been added to ResearchAndMarkets.com’s
offering.

The report predicts the global pigmentation disorders treatment market
to grow with a CAGR of 5.9% over the forecast period from 2018-2024.

The report on the global pigmentation disorders treatment market
provides qualitative and quantitative analysis for the period from 2016
to 2024. The study on pigmentation disorders treatment market covers the
analysis of the leading geographies such as North America, Europe,
Asia-Pacific, and RoW for the period of 2016 to 2024.

The report on pigmentation disorders treatment market is a comprehensive
study and presentation of drivers, restraints, opportunities, demand
factors, market size, forecasts, and trends in the global pigmentation
disorders treatment market over the period of 2016 to 2024. Moreover,
the report is a collective presentation of primary and secondary
research findings.

Porter’s five forces model in the report provides insights into the
competitive rivalry, supplier and buyer positions in the market and
opportunities for the new entrants in the global pigmentation disorders
treatment market over the period of 2016 to 2024. Further, the author’s
growth matrix given in the report brings an insight into the investment
areas that existing or new market players can consider.

Report Findings

1. Drivers

  • Growing demand for several skin treatment products
  • Growing awareness about skin problem and availability of treatment
    remedy among consumers

2. Restraints

  • Costly treatment procedure of pigmentation disorder

3. Opportunities

  • Growth in medical tourism

What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of
the pigmentation disorders treatment market.

2. Complete coverage of all the segments in the pigmentation disorders
treatment market to analyze the trends, developments in the global
market and forecast of market size up to 2024.

3. Comprehensive analysis of the companies operating in the global
pigmentation disorders treatment market. The company profile includes
analysis of product portfolio, revenue, SWOT analysis and latest
developments of the company.

4. The growth matrix presents an analysis of the product segments and
geographies that market players should focus to invest, consolidate,
expand and/or diversify.

Key Topics Covered:

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

2.1. Pigmentation Disorders Treatment Market Highlights

2.2. Pigmentation Disorders Treatment Market Projection

2.3. Pigmentation Disorders Treatment Market Regional Highlights

3. Global Pigmentation Disorders Treatment Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter’s Five Forces Analysis

3.4. Growth Matrix Analysis

3.4.1. Growth Matrix Analysis by Treatment & Therapies

3.4.2. Growth Matrix Analysis by Disease Indication

3.4.3. Growth Matrix Analysis by End-user

3.4.4. Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Pigmentation Disorders Treatment Market

4. Pigmentation Disorders Treatment Market Macro Indicator
Analysis

5. Global Pigmentation Disorders Treatment Market by Treatment &
Therapies

5.1. Chemical Peels

5.2. Dermabrasion

5.3. Laser Resurfacing

5.4. Melasma

5.5. Others

6. Global Pigmentation Disorders Treatment Market by Disease
Indication

6.1. Hypopigmentation

6.2. Hyperpigmentation

7. Global Pigmentation Disorders Treatment Market by End-user

7.1. Dermatology Clinics

7.2. Hospitals

7.3. Others

8. Global Pigmentation Disorders Treatment Market by Region
2018-2024

9. Company Profiles and Competitive Landscape

9.1. Competitive Landscape in the Global Pigmentation Disorders
Treatment Market

9.2. Companies Profiles

9.2.1. Bayer AG

9.2.2. Pierre Fabre Pharmaceuticals

9.2.3. EpiPharm AG

9.2.4. SkinCeuticals International

9.2.5. Galderma laboratories

9.2.6. VIVIERPHARMA

9.2.7. Obagi Cosmeceuticals LLC.

9.2.8. La Roche-Posay

9.2.9. Allergan

For more information about this report visit https://www.researchandmarkets.com/r/mvxgct

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Dermatological
Drugs